Key result
The slow skeletal muscle myosin isoform (MHC-1) exhibits a biphasic dissociation of actin-myosin by ATP and slow isomerizations in ADP displacement, distinguishing its kinetic properties from MHC-2.
The slow skeletal muscle isoform of myosin (MHC-1) exhibits complex, biphasic actin-myosin dissociation kinetics and multiple ADP-bound states, similar to some non-muscle myosins.
Distinguishes MHC-1 kinetics in animal models; leaves open translation to human muscle disorders or therapies.
Fast and slow mammalian muscle myosins differ in the heavy chain sequences (MHC-2, MHC-1) and muscles expressing the two isoforms contract at markedly different velocities. One role of slow skeletal muscles is to maintain posture with low ATP turnover, and MHC-1 expressed in these muscles is identical to heavy chain of the beta-myosin of cardiac muscle. Few studies have addressed the biochemical kinetic properties of the slow MHC-1 isoform. We report here a detailed analysis of the MHC-1 isoform of the rabbit compared with MHC-2 and focus on the mechanism of ADP release. We show that MHC-1, like some non-muscle myosins, shows a biphasic dissociation of actin-myosin by ATP. Most of the actin-myosin dissociates at up to approximately 1000 s(-1), a very similar rate constant to MHC-2, but 10-15% of the complex must go through a slow isomerization (approximately 20 s(-1)) before ATP can dissociate it. Similar slow isomerizations were seen in the displacement of ADP from actin-myosin.ADP and provide evidence of three closely related actin-myosin.ADP complexes, a complex in rapid equilibrium with free ADP, a complex from which ADP is released at the rate required to define the maximum shortening velocity of slow muscle fibers (approximately 20 s(-1)), and a third complex that releases ADP too slowly (approximately 6 s(-1)) to be on the main ATPase pathway. The role of these actin-myosin.ADP complexes in the mechanochemistry of slow muscle contraction is discussed in relation to the load dependence of ADP release.
No takes yet. Share an insight, caveat, or question.
Iorga et al. (2006) studied this question. MHC-1 isoform (slow skeletal muscle myosin) vs. MHC-2 isoform was evaluated on Biochemical kinetic properties (mechanism of ADP release). The slow skeletal muscle myosin isoform (MHC-1) exhibits a biphasic dissociation of actin-myosin by ATP and slow isomerizations in ADP displacement, distinguishing its kinetic properties from MHC-2.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: